Portugal, Feb. 9 -- Portugal based Gilead Sciences, Lda. has secured contract from Instituto Portugues De Oncologia Do Porto Francisco Gentil, Epe for 1778325 - Autotransdanti-Cd19 Cd3 Cells 04-2X10e8 Cell Disp Inj 68 Ml (Brexucabtagene). The value of the contract is worth 34200000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....